Cell culture platform for single cell sorting and enhanced reprogramming of ipscs
US-2026035672-A1 · Feb 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Flynn Peter patents
Flynn Peter is listed as an inventor on 28 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Flynn Peter |
| Total patents | 28 |
| First publication | Apr 9, 2015 |
| Latest publication | Feb 5, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
US-12415989-B2 · Sep 16, 2025 · US
Minimal volume reprogramming of mononuclear cells
US-12264322-B2 · Apr 1, 2025 · US
Compositions and methods to regulate Renalase in the treatment of cancer
US-12152085-B2 · Nov 26, 2024 · US
Treatment of cancer with nk cells and a cd20 targeted antibody
US-2024000840-A1 · Jan 4, 2024 · US
Compositions and Methods to Regulate Renalase in the Treatment of Cancer
US-2022281996-A1 · Sep 8, 2022 · US
Reprogramming methods and cell culture platforms
US-2022228125-A1 · Jul 21, 2022 · US
Compositions and methods to regulate Renalase in the treatment of cancer
US-11370846-B2 · Jun 28, 2022 · US
Reprogramming methods and cell culture platforms
US-11268069-B2 · Mar 8, 2022 · US
Minimal volume reprogramming of mononuclear cells
US-2021198687-A1 · Jul 1, 2021 · US
Recent patents
Latest publications not already listed above.
Minimal volume reprogramming of mononuclear cells
US-10954529-B2 · Mar 23, 2021 · US
Cell culture platform for single cell sorting and enhanced reprogramming of ipscs
US-2021079359-A1 · Mar 18, 2021 · US
Compositions and Methods to Regulate Renalase in the Treatment of Cancer
US-2021024652-A1 · Jan 28, 2021 · US
Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
US-10844356-B2 · Nov 24, 2020 · US
Antibody to Renalase
US-10618975-B2 · Apr 14, 2020 · US
Compositions and Methods to Regulate Renalase in the Treatment of Cancer
US-2019194355-A1 · Jun 27, 2019 · US
Compositions to regulate renalase in the treatment of diseases and disorders
US-10273311-B2 · Apr 30, 2019 · US
Minimal volume reprogramming of mononuclear cells
US-2018355373-A1 · Dec 13, 2018 · US
Minimal volume reprogramming of mononuclear cells
US-10023879-B2 · Jul 17, 2018 · US
Wnt compositions and therapeutic uses of such compositions
US-9873722-B2 · Jan 23, 2018 · US
Cell culture platform for single cell sorting and enhanced reprogramming of ipscs
US-2017362569-A1 · Dec 21, 2017 · US
Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
US-9732319-B2 · Aug 15, 2017 · US
Compositions and Methods to Regulate Renalase in the Treatment of Diseases and Disorders
US-2017226228-A1 · Aug 10, 2017 · US
Improved reprogramming methods and cell culture platforms
US-2017073643-A1 · Mar 16, 2017 · US
Wnt compositions and therapeutic uses of such compositions
US-9403885-B2 · Aug 2, 2016 · US
Minimal volume reprogramming of mononuclear cells
US-2015376646-A1 · Dec 31, 2015 · US
Humaneered anti-factor B antibody
US-9096677-B2 · Aug 4, 2015 · US
Wnt compositions and therapeutic uses of such compositions
US-2015099708-A1 · Apr 9, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Fate Therapeutics Inc | 18 |
| Univ Yale | 8 |
| Flynn Peter | 3 |
| Lee Tom Tong | 2 |
| Fitch Michael J | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 10 |
| C12N2501/727 | 9 |
| C12N5/0606 | 9 |
| C12N2501/603 | 9 |
| C12N2501/415 | 9 |